Regret Comes Too Late: Getting Ahead of Protocol Amendments
September 8th 2020Welcome back to the Forum for EmergingBio's Outsourcing Decisions! There is nothing quite like protocol amendments to put the brakes on a clinical trial’s momentum, which is why, in this blog, we are turning our attention to how to face this challenge head on.
Bioforum, the Forum for EmergingBio's Outsourcing Decisions
June 30th 2020As the biopharma industry traverses unchartered waters amid the COVID-19 crisis and doubles down on its efforts to bring new therapies to market faster, cheaper and without affecting quality, the success of strategic partnerships and functional service provider models will become more critical than ever before.